BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 24778075)

  • 41. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
    Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
    Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-to-muscle ratio of 8F-FDG PET for predicting histologic features and recurrence of HCC.
    Baek YH; Lee SW; Jeong YJ; Jeong JS; Roh YH; Han SY
    Hepatogastroenterology; 2015; 62(138):383-8. PubMed ID: 25916068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.
    Choi HJ; Kang CM; Jo K; Lee WJ; Lee JH; Ryu YH; Lee JD
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):841-7. PubMed ID: 25216749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET.
    Kornberg A; Küpper B; Thrum K; Wilberg J; Sappler A; Gottschild D
    Am J Transplant; 2009 Nov; 9(11):2631-6. PubMed ID: 19775312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
    Ahn SG; Park JT; Lee HM; Lee HW; Jeon TJ; Han K; Lee SA; Dong SM; Ryu YH; Son EJ; Jeong J
    Breast Cancer Res; 2014; 16(6):502. PubMed ID: 25551703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
    Querellou S; Abgral R; Le Roux PY; Nowak E; Valette G; Potard G; Le Duc-Pennec A; Cavarec MB; Marianovski R; Salaün PY
    Head Neck; 2012 Apr; 34(4):462-8. PubMed ID: 21604320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Application of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of hilar cholangiocarcinoma].
    Gu XJ; Wang BF; Liu R
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(20):1409-12. PubMed ID: 22883200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Value of Restaging F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict 3-Year Post-Recurrence Survival in Patients with Recurrent Gastric Cancer after Curative Resection.
    Kim SH; Song BI; Kim HW; Won KS; Son YG; Ryu SW
    Korean J Radiol; 2020 Jul; 21(7):829-837. PubMed ID: 32524783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
    Kluge R; Schmidt F; Caca K; Barthel H; Hesse S; Georgi P; Seese A; Huster D; Berr F
    Hepatology; 2001 May; 33(5):1029-35. PubMed ID: 11343227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer.
    Lee JE; Kim SW; Kim JS; Choi KY; Kang WK; Oh ST; Yoo IeR; Kim SH
    World J Gastroenterol; 2012 Sep; 18(36):5072-7. PubMed ID: 23049216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic value of preoperative positron emission tomography-computed tomography in surgically resected gastric cancer].
    Kim KS; Choi SR; Park IC; Koo TH; Kim JM
    Korean J Gastroenterol; 2014 Jun; 63(6):348-53. PubMed ID: 24953611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ; MacRae R; Sirisegaram A; Pantarotto JR
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):312-8. PubMed ID: 24411602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
    Li J; Kuehl H; Grabellus F; Müller SP; Radunz S; Antoch G; Nadalin S; Broelsch CE; Gerken G; Paul A; Kaiser GM
    J Surg Oncol; 2008 Nov; 98(6):438-43. PubMed ID: 18767120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prognostic value of SUV
    Diao W; Tian F; Jia Z
    Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
    Park JY; Lee JW; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
    J Gynecol Oncol; 2017 May; 28(3):e28. PubMed ID: 28382795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
    Lee SD; Kim SH; Kim YK; Kim C; Kim SK; Han SS; Park SJ
    Transpl Int; 2013 Jan; 26(1):50-60. PubMed ID: 23106431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at
    Sabaté-Llobera A; Gràcia-Sánchez L; Reynés-Llompart G; Ramos E; Lladó L; Robles J; Serrano T; Mestres-Martí J; Gámez-Cenzano C
    Clin Transl Oncol; 2019 Mar; 21(3):324-333. PubMed ID: 30022384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.